PNV Long-term Polynovo shareholders see relief as US Medicare changes offer boon Healthcare player Polynovo (ASX:PNV) has offered relief to long-term shareholders who may have been bemoaning 1Y returns down -30%. Jonathon Davidson 2 days ago ASX News Healthcare Medical Devices
4DX Another day, another FDA approval: 4D Medical pops +30% on keystone reg tick 4D Medical (ASX:4DX) shares soared over +30% intraday as the company’s the latest biotech to come to the market with news of an FDA approval @ for a biotech stock, the same thing as hitting bonanza gold grades.Listen to the HotCopper podcast for in-depth discussions and insights o... Jonathon Davidson 3 days ago ASX News Healthcare Technology Scientific & Technical Instruments
MSB Mesoblast falls -10% on earnings report; -US$100M loss Mesoblast had HotCopper users divided on whether the company's fortunes are anything to worry about based on the nature of a Friday webcast. Jonathon Davidson 6 days ago ASX News Healthcare Biotechnology
TLX More pain for Telix after PET scan agent knocked back by FDA Telix (ASX:TLX) has experienced a jolt in its recovery after its quarterly – now, the FDA has knocked back an investigational PET scan agent. Jonathon Davidson 7 days ago ASX News Healthcare Biotechnology
SIG Sigma: Chemist Warehouse merger has created 'stronger, more integrated' biz Sigma Healthcare (ASX:SIG) was up as much as +6% in afternoon trade on Wednesday after coming out swinging with its first full-year results since the reverse listing of Chemist Warehouse. And the numbers are big.Listen to the HotCopper podcast for in-depth discussions and insights on all the bigg... Sean Boss 27 Aug 2025 13:40 (AEST) ASX News Healthcare Drug Manufacturers - Major
NUZ Neurizon NUZ-001 OLE study demonstrates long-term safety, efficacy signals HotCopper sat down with Neurizon Therapeutics MD Michael Thurn to discuss the clinical-stage biotech company's latest NUZ-001 OLE study. Isaac McIntyre 21 Aug 2025 14:57 (AEST) ASX News The Watchlist Healthcare Biotechnology
AYA Artrya Ltd joins top gainers with +36% jump on FDA greenlight Artrya has seen its shares pop +40% in Thursday trades as the company declares a fresh FDA approval that could unlock revenue pathways. Jonathon Davidson 21 Aug 2025 12:41 (AEST) ASX News Healthcare Medical Care
RMD ResMed up on bullish analyst notes after solid quarter ResMed (ASX:RMD) is still batting eyelashes at brokers, with Ord Minnett reaffirming its @Buy” rating following what it called a @solid” quarterly performance.Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headl... Sean Boss 20 Aug 2025 13:41 (AEST) ASX 200 ASX News Healthcare Technology Scientific & Technical Instruments
CSL CSL price walloped -10% on widespread 'cost-saving' job cuts, Seqirus spinoff plans Earnings day hasn’t quite been a shining one for CSL Ltd (ASX:CSL), with the $117 billion biotechnology bluechip unveiling plans to trim its global workforce by as much as 15% as it looks to save $550 million annually.Listen to the HotCopper podcast for in-depth discussions and in... Isaac McIntyre 19 Aug 2025 11:36 (AEST) ASX 200 ASX News Healthcare Biotechnology
TTX Recent ASX debutant Tetratherix locks in A$3.3M gov't grant for healtech Tetratherix (ASX:TTX) has jumped +3% heading into lunchtime trades as the company secures a $3.3M government... Jonathon Davidson 14 Aug 2025 13:54 (AEST) ASX News Healthcare Biotechnology
RCE Recce answers US Defence call with 'highly effective' R327 gel for burn wounds The Recce 327 Topical Gel is @highly effective” for treating infected burn wounds @ and it works quickly too @ Recce Pharmaceuticals (ASX:RCE) confirmed in ongoing tests, setting the stage for a U.S. Defence partnership.Listen to the HotCopper podcast for in-depth discussion... Isaac McIntyre 14 Aug 2025 10:00 (AEST) ASX News The Watchlist Healthcare Biotechnology
RCE Recce eyes US Defence grants with early data for R327 on burn wounds Recce Pharma (ASX:RCE) has notched modest gains in the Tuesday arvo session after reporting its R327 anti-infective gel... Jonathon Davidson 12 Aug 2025 13:21 (AEST) ASX News Healthcare Biotechnology
NEU Neuren Pharma jumps on DAYBUE sales win; short sellers' report now history Dual-listed across the NASDAQ and ASX, Neuren Pharma (ASX:NEU) has jumped +7% down under in the morning Thursday session as... Jonathon Davidson 07 Aug 2025 11:41 (AEST) ASX News Healthcare Biotechnology